
Hunter researchers have received international backing for their work to reduce high rates of cancer survivors dying from cardiovascular disease.
Professors Aaron Sverdlov and Doan Ngo lead a team at Hunter Medical Research Institute that is developing a drug combination that treats cancer and protects the heart.